TOKYO, Jun 08 (Pulse News Wire) – RIBOMIC Inc. (4591.T) has decided to suspend the exercise of its 19th tranche warrant (with adjusted exercise price clause).
The suspension will begin on June 15, 2026, and end on September 18, 2026, covering a 68 trading day period. As of today, there are 91,600 warrants outstanding. This decision follows a buyback agreement with EVO FUND, which was established upon issuance of the warrant on August 08, 2025.
Details of the warrant issuance can be found in the July 23, 2025, press release titled “Third-party allocation for the issuance of the 18th through 20th tranches of warrants (with adjusted exercise price clause) and the conclusion of the warrant repurchase contract.” Under the terms of the buyback agreement, RIBOMIC retains the right to halt or resume warrant exercises at any time during the suspension period. The company plans to disclose any changes in exercise status via timely filings to the Tokyo Stock Exchange. Based on stock price trends, RIBOMIC may choose to pause or restart warrant exercises.
Any such actions will be communicated promptly through appropriate channels.
🟢 Confidence: High AI-translated content.